XML 44 R31.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Financial Highlights - Schedule of Financial Highlights (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Net asset value at beginning of period (in dollars per share) $ 0.18 $ 4.44 $ 13.75 $ 14.82 $ 17.7 $ 26.69
Income from investment operations:            
Net investment income (loss), before deferred taxes (in dollars per share) 0.41 0.16 [1] (1.81) [1] 0.44 [1] 0.09 [1] 0.9 [1]
Deferred tax benefit (in dollars per share) 0 0 0 0 0 (0.08)
Net investment gain (losses) (in dollars per share) 0.41 0.16 (1.81) 0.44 0.09 0.82
Net realized and unrealized gains (losses) on investments, before deferred taxes (in dollars per share) (0.57) (4.42) (7.5) (1.51) (2.3) (12.15)
Deferred tax expense (in dollars per share) 0 0 0 0 (1.13) 2.34
Net realized and unrealized gains (losses) on investments, after deferred taxes (in dollars per share) (0.57) (4.42) (7.5) (1.51) (3.43) (9.81)
Total from investment operations (in dollars per share) (0.16) (4.26) (9.31) (1.07) (3.34) (8.99)
Distributions from:            
Realized capital gains (in dollars per share) 0 0 0 0 0 0
Anti-dilutive effect from capital share transactions (in dollars per share) 0 0 0 0 0.46 0
Net asset value at end of period (in dollars per share) 0.02 0.18 4.44 13.75 14.82 17.7
Market value at end of period (in dollars per share) $ 0.26 $ 0.3 $ 0.95 $ 4.01 $ 4.47 $ 6.43
Total Return            
Based on Net Asset Value (88.89%) (95.95%) (67.71%) (7.22%) (16.27%) (33.68%)
Based on Market Value (13.33%) (68.42%) (76.31%) (10.29%) (30.48%) (42.59%)
End of period $ 167,920 $ 1,260,371 $ 30,609,591 $ 94,800,000 $ 102,100,000 $ 127,100,000
Before tax (benefit)/expense 1567.59% [2] 7.21% (4.11%) (3.12%) [3] (3.10%) [3] 2.84% [3]
Deferred tax (benefit)/expense(3)(4) [4],[5] 0.00% [2] 0.00% [6] 0.00% [6] 0.00% (8.02%) 9.91%
Total expenses (1567.59%) [2] (7.21%) 4.11% 3.12% [3] 11.12% [3] (12.75%) [3]
Total expenses, excluding incentive fees and deferred tax expense (1567.59%) [2] (7.21%) 4.11% 3.12% 3.10% 2.80%
Total expenses, excluding incentive fees, deferred tax expense and fee waiver 140.95% [2] 11.91% 4.11% 3.12% 3.10% 2.80%
Before tax benefit 1585.64% [2] 8.13% (20.96%) 2.94% 0.64% 3.93%
Deferred tax benefit (4)(6) [5],[7] 0.00% [2] 0.00% 0.00% 0.00% 0.00% (0.33%)
Net investment income (loss) 1585.64% [2] 8.13% (20.96%) 2.94% 0.64% 3.60%
Net investment income before fee waiver (122.90%) [2] (10.99%) (20.96%) 2.94% 0.64% 3.60%
Portfolio turnover rate 0.00% [8],[9] 1.00% 15.00% 16.00% 13.00% 18.00%
[1] Calculated using average shares outstanding.
[2] Annualized.
[3] Amount includes the incentive fee. For the year ended December 31, 2019, the ratio of the incentive fee to average net assets was (5.64)%.
[4] Deferred tax expense estimate is derived from net investment income (loss), and realized and unrealized gains (losses).
[5] The deferred tax expense and tax benefit are based on average net assets.
[6] As restated to reflect the removal of parenthetical notation to appropriately present ratio as deferred tax expense.
[7] Deferred tax benefit estimate for the ratio calculation is derived from net investment income (loss) only.
[8] Less than 1%
[9] Not Annualized.